FDA Commissioner Weighs in on Cannabis-Derived Products

Share Post

U.S. Food and Drug Administration (FDA) released a statement by FDA Commissioner Scott Gottlieb, MD outlining the agency’s current actions regarding possible regulatory approaches for cannabis-containing and cannabis-derived products.

Was this article helpful?
YesNo

Links: